GlassScriptPhysician profile
Stacey Alison Thomas
NPI 1922324581
$3,301.84
in general payments reported to CMS, 2019-2025
19 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2020: $1,152 · 2021: $265 · 2022: $733 · 2023: $207 · 2024: $284 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $618.92 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,782.05 | 2019-2022 | |
| Exeltis, USA INC. | $233.15 | 2021-2025 | Slynd |
| Boston Scientific Corporation | $225.00 | 2019 | |
| Biogen, INC. | $167.00 | 2024-2025 | Zurzuvae |
| Gynesonics, INC. | $160.59 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Shield Therapeutics INC | $159.00 | 2023-2024 | Accrufer |
| Evofem Biosciences, INC. | $139.31 | 2022-2025 | Phexxi, Solosec, Phexx |
| Astellas Pharma US INC | $117.90 | 2023-2024 | Veozah |
| Lupin INC. | $57.04 | 2019 | |
| Heron Therapeutics, INC. | $45.63 | 2023 | Zynrelef |
| Merck Sharp & Dohme LLC | $41.92 | 2019-2024 | Gardasil, Gardasil 9 |
| Scynexis, INC. | $40.18 | 2022 | |
| Coopersurgical, INC. | $33.61 | 2019-2024 | Summit Doppler |
| Organon LLC | $24.08 | 2025 | Nexplanon |
| Pfizer INC. | $19.74 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $19.53 | 2024 | |
| Amag Pharmaceuticals, INC. | $16.08 | 2019 | |
| Myovant Sciences INC. | $14.92 | 2022 | |
| Mayne Pharma Commercial LLC | $5.11 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.